285 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Purchased by Kavar Capital Partners LLC

Kavar Capital Partners LLC acquired a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 285 shares of the medical equipment provider’s stock, valued at approximately $149,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Icon Wealth Partners LLC purchased a new stake in Intuitive Surgical during the first quarter worth about $26,000. Manchester Financial Inc. purchased a new stake in Intuitive Surgical during the second quarter worth about $25,000. Advisory Alpha LLC purchased a new position in shares of Intuitive Surgical in the first quarter worth about $32,000. Harvest Group Wealth Management LLC purchased a new position in shares of Intuitive Surgical in the first quarter worth about $44,000. Finally, FTB Advisors Inc. increased its stake in shares of Intuitive Surgical by 333.3% in the first quarter. FTB Advisors Inc. now owns 78 shares of the medical equipment provider’s stock worth $44,000 after purchasing an additional 60 shares in the last quarter. Institutional investors and hedge funds own 86.09% of the company’s stock.

Several equities analysts have recently weighed in on ISRG shares. Northland Securities set a $375.00 target price on shares of Intuitive Surgical and gave the stock a “sell” rating in a research note on Friday, July 19th. Canaccord Genuity reiterated a “buy” rating and issued a $610.00 target price (up previously from $575.00) on shares of Intuitive Surgical in a research note on Friday, July 19th. Zacks Investment Research downgraded shares of Intuitive Surgical from a “hold” rating to a “sell” rating in a research note on Wednesday, April 24th. Raymond James reduced their target price on shares of Intuitive Surgical from $630.00 to $610.00 and set an “outperform” rating for the company in a research note on Monday, April 22nd. Finally, Piper Jaffray Companies lifted their target price on shares of Intuitive Surgical from $610.00 to $633.00 and gave the stock an “overweight” rating in a research note on Friday, July 19th. Three research analysts have rated the stock with a sell rating, three have assigned a hold rating and ten have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $579.92.

In related news, VP Jamie Samath sold 130 shares of the business’s stock in a transaction that occurred on Monday, June 10th. The shares were sold at an average price of $500.60, for a total transaction of $65,078.00. Following the completion of the transaction, the vice president now owns 219 shares of the company’s stock, valued at $109,631.40. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, COO Salvatore Brogna sold 1,172 shares of the business’s stock in a transaction that occurred on Monday, June 10th. The shares were sold at an average price of $500.60, for a total transaction of $586,703.20. Following the transaction, the chief operating officer now directly owns 5,933 shares of the company’s stock, valued at approximately $2,970,059.80. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 25,655 shares of company stock valued at $13,552,920. 1.70% of the stock is owned by corporate insiders.

Shares of NASDAQ:ISRG opened at $499.87 on Friday. The company has a 50 day moving average of $524.23 and a 200 day moving average of $526.47. The stock has a market cap of $59.70 billion, a P/E ratio of 52.67, a P/E/G ratio of 3.85 and a beta of 1.12. Intuitive Surgical, Inc. has a 12 month low of $430.24 and a 12 month high of $589.32.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $3.25 EPS for the quarter, beating the consensus estimate of $2.23 by $1.02. The company had revenue of $1.10 billion during the quarter, compared to analysts’ expectations of $1.03 billion. Intuitive Surgical had a net margin of 29.95% and a return on equity of 17.35%. Intuitive Surgical’s revenue for the quarter was up 20.9% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.76 earnings per share. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 10.15 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.

See Also: What is the downside to momentum investing?

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.